AU4408897A - Method of treating retinal ischemia and glaucoma, using optically pure r- or rr- isomers of adrenergic beta-2 agonists - Google Patents

Method of treating retinal ischemia and glaucoma, using optically pure r- or rr- isomers of adrenergic beta-2 agonists

Info

Publication number
AU4408897A
AU4408897A AU44088/97A AU4408897A AU4408897A AU 4408897 A AU4408897 A AU 4408897A AU 44088/97 A AU44088/97 A AU 44088/97A AU 4408897 A AU4408897 A AU 4408897A AU 4408897 A AU4408897 A AU 4408897A
Authority
AU
Australia
Prior art keywords
glaucoma
agonists
isomers
optically pure
retinal ischemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44088/97A
Inventor
E. Charles Jr. +di Pesterfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ec Pesterfield Associates Inc
Original Assignee
E C PESTERFIELD ASSOC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E C PESTERFIELD ASSOC Inc filed Critical E C PESTERFIELD ASSOC Inc
Publication of AU4408897A publication Critical patent/AU4408897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU44088/97A 1996-07-05 1997-07-03 Method of treating retinal ischemia and glaucoma, using optically pure r- or rr- isomers of adrenergic beta-2 agonists Abandoned AU4408897A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2189996P 1996-07-05 1996-07-05
US2190296P 1996-07-05 1996-07-05
US60021902 1996-07-05
US60021899 1996-07-05
PCT/US1997/011789 WO1998001099A2 (en) 1996-07-05 1997-07-03 Method of treating retinal ischemia and glaucoma

Publications (1)

Publication Number Publication Date
AU4408897A true AU4408897A (en) 1998-02-02

Family

ID=26695224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44088/97A Abandoned AU4408897A (en) 1996-07-05 1997-07-03 Method of treating retinal ischemia and glaucoma, using optically pure r- or rr- isomers of adrenergic beta-2 agonists

Country Status (2)

Country Link
AU (1) AU4408897A (en)
WO (1) WO1998001099A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1058546A4 (en) * 1998-03-06 2004-07-28 Univ Texas Composition and method for treating macular disorders
US6462066B2 (en) 1999-12-02 2002-10-08 University Of South Florida Method and composition for treatment of ischemic neuronal reperfusion injury
EP2064174B1 (en) 2006-08-10 2016-10-26 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Preparation of (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
WO2011112867A1 (en) 2010-03-10 2011-09-15 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3885047A (en) * 1972-06-16 1975-05-20 Mead Johnson & Co Ocular hypotensive process employing dextrorotatory phenethanolamines

Also Published As

Publication number Publication date
WO1998001099A3 (en) 1998-03-19
WO1998001099A2 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
AU4220997A (en) Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders
AU4520697A (en) Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation
EP1040827A3 (en) Use of 2-alkylpyrrolidines for the treatment of diabetes
AU6064696A (en) Water and oil repellent composition, treating method therewith and copolymer
AU3154295A (en) Method for preserving cells, and uses of said method
PH11996053280B1 (en) Recombinant hexose oxidase, a method of producing same and use of such enzyme
AU6281096A (en) Low viscosity, high concentration drag reducing agent and method therefor
AU4437097A (en) Ethylene alpha-olefin block copolymers and methods for production thereof
AU4967997A (en) Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
AU2675095A (en) Indol derivatives useful for the treatment of migraine, composition and utilization
AU674638B2 (en) Composition for the oxidation dyeing of keratinous fibres, and dyeing process using this composition
AU4409597A (en) Method and system for establishing and maintaining user-controlled anonymous communications
WO1998021182A3 (en) Use of cis-δ4 analogs of prostaglandins as ocular hypotensives
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
AU7938294A (en) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes
AU7134698A (en) Spinning apparatus, method of producing yarns, and resulting yarns
AU4408897A (en) Method of treating retinal ischemia and glaucoma, using optically pure r- or rr- isomers of adrenergic beta-2 agonists
AU1495197A (en) Method of treating leather with amphoteric polymers
CA2180846A1 (en) Method of treating disorders of the eye
EP1000619A3 (en) Method for treating glaucoma
AU5218398A (en) Compositions for treating soils, method of preparation and use thereof
AU1074299A (en) Methods and kits for removing, treating or preventing lice
AU4178497A (en) HTm4, methods of treatment and assays, agonists and antagonists
EP0892639A4 (en) Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists
AU3694795A (en) Novel oligomers, process for their preparation and methods for their use